Lebrikizumab

Lebrikizumab is an IgG4 humanized monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. Lebrikizumab can be used for the research of asthma.
Read more
€0.00 (tax incl.)
Reference:
HY-P99025
Product Details
HY-P99025

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
Application
COVID-19-immunoregulation
CAS
953400-68-5

Menu

Settings